| P50 | author | Aliye Uc | Q60568034 |
| | Nicholas J. Schork | Q63005429 |
| | David C Whitcomb | Q96756221 |
| P2093 | author name string | Mark E Lowe | |
| | Stephen J Pandol | |
| | Marshall J Glesby | |
| | Marc T Goodman | |
| | Vikesh K Singh | |
| | Gregory A Coté | |
| | Dana K Andersen | |
| | Mark Haupt | |
| P2860 | cites work | Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene | Q24311652 |
| | Genetics of pancreatitis | Q27000406 |
| | SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis | Q28138406 |
| | Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis | Q28145585 |
| | Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance | Q29615569 |
| | Serum amylase and lipase and urinary trypsinogen and amylase for diagnosis of acute pancreatitis | Q29994579 |
| | Human pluripotent stem cell-derived acinar/ductal organoids generate human pancreas upon orthotopic transplantation and allow disease modelling | Q30313776 |
| | Cystic Fibrosis and Its Management Through Established and Emerging Therapies. | Q30384797 |
| | Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis | Q30528817 |
| | A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis | Q30815377 |
| | LEADER 3--lipase and amylase activity in subjects with type 2 diabetes: baseline data from over 9000 subjects in the LEADER Trial | Q30856973 |
| | American Pancreatic Association Practice Guidelines in Chronic Pancreatitis: evidence-based report on diagnostic guidelines | Q33698421 |
| | Genetic Risk in Chronic Pancreatitis: The Trypsin-Dependent Pathway | Q33843764 |
| | Chronic pancreatitis: diagnosis, classification, and new genetic developments | Q34141293 |
| | Endoplasmic reticulum stress is chronically activated in chronic pancreatitis | Q34283421 |
| | Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia | Q34308407 |
| | Alcohol and Smoking as Risk Factors in an Epidemiology Study of Patients With Chronic Pancreatitis | Q34594385 |
| | EUS-based criteria for the diagnosis of chronic pancreatitis: the Rosemont classification | Q34604850 |
| | Association of rare chymotrypsinogen C (CTRC) gene variations in patients with idiopathic chronic pancreatitis | Q34732835 |
| | Cytokine profiling of pancreatic fluid using the ePFT collection method in tandem with a multiplexed microarray assay | Q35048248 |
| | Increased activation of hereditary pancreatitis-associated human cationic trypsinogen mutants in presence of chymotrypsin C | Q36016998 |
| | Pancreatitis Quality of Life Instrument: Development of a new instrument | Q36165877 |
| | Mothers' responses to children's pain | Q36475951 |
| | Variation in the γ-glutamyltransferase 1 gene and risk of chronic pancreatitis | Q36912543 |
| | A starring role for stellate cells in the pancreatic cancer microenvironment | Q37059888 |
| | Emerging targets in pancreatic cancer: epithelial-mesenchymal transition and cancer stem cells | Q37178822 |
| | Association between calcium sensing receptor gene polymorphisms and chronic pancreatitis in a US population: role of serine protease inhibitor Kazal 1type and alcohol | Q37316882 |
| | Variants in CPA1 are strongly associated with early onset chronic pancreatitis | Q37540036 |
| | Insights into the genetic risk factors for the development of pancreatic disease | Q37638790 |
| | Risk Factors Associated With Pediatric Acute Recurrent and Chronic Pancreatitis: Lessons From INSPPIRE. | Q37652912 |
| | A recombined allele of the lipase gene CEL and its pseudogene CELP confers susceptibility to chronic pancreatitis | Q37660241 |
| | Environmental and genetic stressors and the unfolded protein response in exocrine pancreatic function - a hypothesis | Q37864084 |
| | Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus | Q38055715 |
| | Newly diagnosed diabetes mellitus after acute pancreatitis: a systematic review and meta-analysis | Q38127652 |
| | Mutations in the human UBR1 gene and the associated phenotypic spectrum | Q38193717 |
| | Significant elevations of serum lipase not caused by pancreatitis: a systematic review | Q38216840 |
| | Chylomicronaemia--current diagnosis and future therapies | Q38366873 |
| | Mutations of the cystic fibrosis gene in patients with chronic pancreatitis | Q38502091 |
| | Genetic susceptibility factors for alcohol-induced chronic pancreatitis. | Q38543402 |
| | Single-Subject Studies in Translational Nutrition Research. | Q38656373 |
| | Early-Onset Acute Recurrent and Chronic Pancreatitis Is Associated with PRSS1 or CTRC Gene Mutations. | Q38684171 |
| | Cystic fibrosis in the era of precision medicine | Q38735588 |
| | A Novel APOC2 Missense Mutation Causing Apolipoprotein C-II Deficiency With Severe Triglyceridemia and Pancreatitis. | Q38757145 |
| | New Therapeutic Approaches to Modulate and Correct Cystic Fibrosis Transmembrane Conductance Regulator | Q38836754 |
| | New insights into the pathways initiating and driving pancreatitis. | Q38900762 |
| | The Value of Secretin-Enhanced MRCP in Patients With Recurrent Acute Pancreatitis | Q39002811 |
| | An Evaluation of Factors Associated With Pathogenic PRSS1, SPINK1, CTFR, and/or CTRC Genetic Variants in Patients With Idiopathic Pancreatitis | Q39260953 |
| | Novel mutations in the calcium sensing receptor gene in tropical chronic pancreatitis in India | Q39283578 |
| | Genetic risk in chronic pancreatitis: the misfolding-dependent pathway | Q39398523 |
| | Expression of the Shwachman-Bodian-Diamond syndrome (SBDS) protein in human pancreatic cancer and chronic pancreatitis | Q39988179 |
| | Chronic pancreatitis: An international draft consensus proposal for a new mechanistic definition | Q40881901 |
| | Classification of pancreatitis | Q42146854 |
| | Peering Into the "Black Box" of the Complex Chronic Pancreatitis Syndrome | Q42640898 |
| | Endoscopic ultrasound, secretin endoscopic pancreatic function test, and histology: correlation in chronic pancreatitis | Q42981041 |
| | Long-term prognosis of acute pancreatitis in Japan | Q43246770 |
| | Polymorphisms at PRSS1-PRSS2 and CLDN2-MORC4 loci associate with alcoholic and non-alcoholic chronic pancreatitis in a European replication study | Q44741070 |
| | The association between hydroxyurea treatment and pain intensity, analgesic use, and utilization in ambulatory sickle cell anemia patients. | Q44964910 |
| | Administration of secretin (RG1068) increases the sensitivity of detection of duct abnormalities by magnetic resonance cholangiopancreatography in patients with pancreatitis | Q44999076 |
| | Genetics: Global role for CPA1 variants in the pathogenesis of chronic pancreatitis | Q45228989 |
| | Pancreatitis Quality of Life Instrument: A Psychometric Evaluation | Q46350116 |
| | Type 2 Diabetes and Risk of Incident Cancers in China: A Prospective Study among 0.5 Million Chinese Adults | Q47205341 |
| | Towards a neurobiological understanding of pain in chronic pancreatitis: mechanisms and implications for treatment | Q47698063 |
| | Natural history following the first attack of acute pancreatitis | Q47733611 |
| | The druggable genome and support for target identification and validation in drug development. | Q48347170 |
| | Adolescent chronic pain: patterns and predictors of emotional distress in adolescents with chronic pain and their parents | Q49144052 |
| | Drug development in the era of precision medicine. | Q50020853 |
| | Reduction of Recurrence Risk of Pancreatitis in Cystic Fibrosis with Ivacaftor: Case Series. | Q50089194 |
| | Risk of and factors associated with readmission after a sentinel attack of acute pancreatitis. | Q50687852 |
| | Multicenter comparison of the interobserver agreement of standard EUS scoring and Rosemont classification scoring for diagnosis of chronic pancreatitis. | Q53065006 |
| | Preferred designs, outcomes, and analysis strategies for treatment trials in idiopathic recurrent acute pancreatitis. | Q53133022 |
| | International consensus statements on early chronic Pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with The International Association of Pancreatology, America | Q57950923 |
| | The number of tandem repeats in the carboxyl-ester lipase (CEL) gene as a risk factor in alcoholic and idiopathic chronic pancreatitis | Q58436091 |
| | A Loss of Function Polymorphism (G191R) of Anionic Trypsinogen (PRSS2) Confers Protection Against Chronic Pancreatitis | Q61052873 |
| | Recurrent Acute Pancreatitis Significantly Reduces Quality of Life Even in the Absence of Overt Chronic Pancreatitis. | Q64935764 |
| | Do cytokine concentrations in pancreatic juice predict the presence of pancreatic diseases? | Q83816901 |
| | Similar efficacies of biliary, with or without pancreatic, sphincterotomy in treatment of idiopathic recurrent acute pancreatitis | Q84976751 |
| | Informative Patterns of Health-Care Utilization Prior to the Diagnosis of Pancreatic Ductal Adenocarcinoma | Q88144377 |
| | Reflections on Randomized Control Trials | Q88582103 |
| | Recurrent Acute Pancreatitis: International State-of-the-Science Conference With Recommendations | Q89077420 |
| | Chronic pancreatitis: an update on genetic risk factors | Q89101396 |
| | CFTR modulator theratyping: Current status, gaps and future directions | Q89205436 |
| | Defining the diagnostic value of hyperlipasemia for acute pancreatitis in the critically ill | Q89364814 |
| | Hereditary Pancreatitis in the United States: Survival and Rates of Pancreatic Cancer | Q90294639 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | drug delivery | Q1392806 |
| | chronic pancreatitis | Q1996053 |
| | kidney disease | Q1054718 |
| P304 | page(s) | 1193-1199 | |
| P577 | publication date | 2018-11-01 | |
| P1433 | published in | Pancreas | Q15762014 |
| P1476 | title | Accelerating the Drug Delivery Pipeline for Acute and Chronic Pancreatitis: Summary of the Working Group on Drug Development and Trials in Recurrent Acute Pancreatitis at the National Institute of Diabetes and Digestive and Kidney Diseases Workshop | |
| P478 | volume | 47 | |